Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population

Papatheodoridis, George; Sypsa, Vana; Dalekos, George; Yurdaydin, Cihan; van Boemmel, Florian; Buti, Maria; Goulis, John; Calleja, Jose; Chi, Heng; Manolakopoulos, Spilios; Loglio, Alessandro; Siakavellas, Spyros; Gatselis, Nikolaos; KESKİN, ONUR; Lehretz, Maria; Savvidou, Savvoula; de la Revilla, Juan; Hansen, Bettina; Kourikou, Anastasia; Vlachogiannakos, Ioannis; Galanis, Kostantinos; İDİLMAN, RAMAZAN; Colombo, Massimo; Esteban, Rafael; Janssen, Harry; Berg, Thomas; Lampertico, Pietro

doi:10.1016/j.jhep.2018.01.031

Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population

Copy For Citation

Papatheodoridis G. V., Sypsa V., Dalekos G., Yurdaydin C., van Boemmel F., Buti M., ...More

JOURNAL OF HEPATOLOGY, vol.68, no.6, pp.1129-1136, 2018 (SCI-Expanded)

Publication Type: Article / Article
Volume: 68 Issue: 6
Publication Date: 2018
Doi Number: 10.1016/j.jhep.2018.01.031
Journal Name: JOURNAL OF HEPATOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1129-1136
Hacettepe University Affiliated: Yes

Abstract

Background & Aims: The effects of long-term antiviral therapy on survival have not been adequately assessed in chronic hepatitis B (CHB). In this 10-centre, ongoing cohort study, we evaluated the probability of survival and factors affecting survival in Caucasian CHB patients who received long-term entecavir/tenofovir therapy.